What You Should Know:
Sword Health, the world’s fastest-growing platform for treating pain, today announced Predict, the first AI engine using advanced machine learning to identify members who are up to 40x more likely to have surgery, more than 8 months before a decision has been made to operate, to help them avoid unnecessary and costly hip, knee, and back surgeries. With Predict, Sword can utilize a wide range of healthcare and demographic data to identify, engage and treat members
Read More
AI
AI in Healthcare| AI Impact for Researchers, Clinicians| Policy, News, Analysis, Insights - HIT Consultant
ChatGPT Has Potential to Help Cirrhosis, Liver Cancer Patients, Cedars Sinai Study Reveals
What You Should Know:
A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions.The findings, published in the peer-reviewed journal Clinical and Molecular Hepatology, highlight the AI system’s potential to play a role in clinical practice.
Helping
Read More
Siemens Partners with LeanTaaS on Hospital Operational Performance
What You Should Know:
- Siemens Healthineers and LeanTaaS have entered a strategic partnership to help health systems across the country achieve and sustain peak hospital operational performance.
- The Siemens Healthineers network can now deploy system-wide tools designed to optimize capacity supported by the powerful combination of LeanTaaS’ Artificial Intelligence (AI) and Machine Learning (ML) -based predictive and prescriptive analytics solutions and the enterprise-wide management
Read More
Can Technology Live Up to Its Promise for Clinical Trials?
By creating efficiencies with technology, CROs have an opportunity to build clinical trials of the future.
For many years, artificial intelligence (AI), machine learning (ML) and natural language processing (NLP) had a reputation in the biopharmaceutical industry as flashy buzzwords, with little concrete evidence to back up their promise. Over time, this lack of understanding has created drawn-out anticipation, leaving many skeptical about the true value of these tools.
As the
Read More
AI-Enabled Butterfly Network Lung Tool Receives FDA Clearance
What You Should Know:
- Today, Butterfly Network announced it received 510(k) clearance from the FDA for a groundbreaking AI-enabled tool named AI-enabled Auto B-line Counter that will help physicians assess adults’ lungs and accelerate providers’ abilities to make informed treatment decisions. Butterfly used data inputs from hundreds of sites across the country to train and develop its AI algorithms, offering potential for a broad and diverse range of age, gender, body mass index, ethnicity,
Read More
Value-Based Administration Enables All VBC Network Stakeholders to Benefit
Despite holding the promise of delivering superior patient outcomes while lowering healthcare costs, many providers remain reluctant to embrace value-based care (VBC) reimbursement models. Progress toward VBC adoption hasn’t achieved its potential yet, hovering around 60% of all payment models from 2018 to 2021, with the remaining 40% comprised of traditional fee for service (FFS).
Though some providers simply are hesitant to abandon the FFS model that has served them well, others are leery
Read More
Kahun Integrates AI Physician Chatbot with ChatGPT
What You Should Know:
- Kahun, an evidence-based clinical reasoning tool for physicians announced it is integrating its AI chatbot for physicians with ChatGPT, an open-source AI chatbot platform to build on the advanced Large Language Model’s (LLM) ability to engage in human-like conversation with patients.
- By integrating ChatGPT, Kahun builds on the language model’s text fluency to boost patient engagement pre-visit, cutting the time needed for the healthcare provider to conduct the
Read More
Exec Hires: Elucid Appoints Andrew Miller as CTO
What You Should Know:
- Elucid, Inc., a medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, has hired Andrew Miller as its chief technology officer (CTO).
- As CTO, Andrew will lead the technology strategy and oversee the engineering team’s execution. Elucid’s software is the only FDA-cleared non-invasive tool able to accurately characterize arterial plaque, simulating what pathologists would see under a microscope and
Read More
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
What You Should Know:
Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are diagnosed and treatment decisions are made.Taiwania Capital and Debiopharm Innovation Fund co-led the round, with participation from previous investors First Star Ventures, Redalpine Venture Partners, and Pikas. Other new investors include P5 Health
Read More
5 AI-Driven Healthcare Trends and Solutions in 2023
Enterprise-level healthcare is a massive business sector with seemingly infinite moving parts. With patients’ lives at stake, liability is huge, leaving little room for error. Yet human error is common in healthcare, and minor mistakes can cost millions in legal fees and lawsuits, not to mention risks to patient health. Healthcare enterprises are quickly embracing artificial intelligence solutions to mitigate loss, streamline operations, improve efficiency, and enhance customer
Read More
